Company
Zenabis Global Inc.
Headquarters: Vancouver, BC, Canada
Employees: 794
Zenabis Global Inc. Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Zenabis Global Inc. engages in the cultivation and sale of medical and recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-üp brands; and various oil-based cannabis products. It owns 3.5 million square feet of total facility space for production and cultivation. The company is headquartered in Vancouver, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Zenabis Global Inc. has the following listings and related stock indices.
Stock: TSX: ZENA wb_incandescent